How does Strobilanthes crispus work to treat kidney stones?

Strobilanthes crispus exerts its effects primarily through diuretic and anti-lithic properties. The plant contains high levels of potassium and silicic acid, which help increase urine output, potentially flushing out small stones and preventing new crystal formation. Additionally, the flavonoids and glucosides present act as antioxidants, protecting renal tissues from oxidative damage. While these mechanisms are supported by traditional use and preliminary phytochemical analysis, clinical trials are limited, giving it an Evidence Level C.

Is Strobilanthes crispus safe to consume during pregnancy?

No, Strobilanthes crispus is considered unsafe during pregnancy. Traditional medicinal texts and available pharmacological data contraindicate its use for expectant mothers because the herb can stimulate uterine contractions or alter fluid balance. Due to insufficient safety data and potential risks to fetal development, women who are pregnant or breastfeeding should avoid this herb entirely. It is crucial to consult a qualified healthcare provider before using any herbal supplements during pregnancy.

What is the recommended dosage for Strobilanthes crispus tea?

The standard adult dosage for Strobilanthes crispus is 3 to 5 grams of dried leaves prepared as a tea, taken up to three times daily. This preparation is traditionally used to support kidney health and manage blood sugar levels. Users should not exceed this recommended amount, as excessive intake can lead to side effects such as nausea or electrolyte imbalances. Dosage recommendations are based on traditional use (Evidence Level C) rather than standardized clinical trials.

Does Strobilanthes crispus interact with blood pressure or diabetes medications?

Yes, Strobilanthes crispus has potential interactions with antihypertensive and antidiabetic drugs. Because the herb acts as a diuretic and may lower blood glucose, taking it alongside prescription diuretics or diabetes medications could potentiate effects, leading to hypotension or hypoglycemia. Patients managing hypertension or diabetes should monitor their levels closely and consult a physician before adding this herb to their regimen to avoid adverse interactions (Evidence Level C).

Can Strobilanthes crispus help lower high blood pressure?

Strobilanthes crispus is traditionally used to treat hypertension, primarily due to its diuretic action. By increasing urine production, the herb helps reduce blood volume, which can subsequently lower blood pressure. The presence of potassium and specific flavonoids supports cardiovascular health. However, while animal studies suggest a benefit, there is a lack of robust human clinical trials to confirm efficacy. Therefore, it should not replace prescribed antihypertensive medication without medical supervision (Evidence Level C).

Strobilanthes Crispus (Strobilanthes crispus)

Fiche d'information compilée à partir de PubMed

Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.

Compilé à partir de 30 articles PubMed · modèle : gemma4:31b

Résumé

Strobilanthes crispus is a medicinal herb native to Malaysia and the Malay Archipelago, traditionally used for cancer, diabetes, and immune system support [PMID:36046107, PMID:33127562, PMID:20684795].

Contexte

Strobilanthes crispus (Acanthaceae family), also known as Batuzin, Bayam Karang, Kotz Bellin, Pekka Batu, Pecah kaca, or Jin batu, is a plant native to Malaysia [PMID:36046107, PMID:30594607, PMID:33127562].

Usages traditionnels

Traditionally used for the treatment of cancer, gastrointestinal disorders, inflammatory wounds of snake bites, kidney stones, diabetes, hypertension, and to boost the immune system [PMID:30594607, PMID:33127562, PMID:29100935, PMID:27844243]. It has also been used as a diuretic, antilytic, and laxative [PMID:16688478, PMID:22471785].

Composés actifs

Identified constituents include lutein, β-sitosterol, and stigmasterol [PMID:33127562, PMID:33906591]. Other reported metabolites include indolo-quinazoline alkaloids, flavonoids, phenolic acids, sterols, terpenoids, tannins, caffeine, and α-linolenic acid [PMID:42005722, PMID:11137889, PMID:30970652].

Mécanisme d'action

The herb's bioactive subfraction F3 inhibits breast cancer metastasis by affecting markers such as E-cadherin, MMP-9, MUC-1, N-cadherin, Twist, VEGF, and vimentin [PMID:30594607]. It exhibits anti-glycolytic activity by inhibiting the localization of GLUT1 to the cell membrane via reduction in PKC activity and increased TXNIP protein expression [PMID:37259304]. It may induce apoptosis through the mitochondria-dependent p53 pathway [PMID:22471785] or by suppressing BCL-2 protein expression [PMID:33511882]. Additionally, it stimulates anti-tumor immunogenicity by increasing MHC class I and II molecules and infiltrating CD4+, CD8+, and IL-2+ cells into the tumor microenvironment [PMID:35972917].

Preuves cliniques

Preuve DBreast Cancer

Bioactive subfraction F3 inhibited tumor progression, migration, and metastasis in 4T1-induced mouse mammary carcinoma models [PMID:30594607, PMID:33127562].

Preuve DColon Cancer

Ethanol extract significantly inhibited colorectal carcinogenesis and reduced aberrant crypt foci (ACF) in rats [PMID:26307342, PMID:26608653].

Preuve DHyperglycemia

Hot water extracts of fermented and unfermented tea reduced blood glucose in streptozotocin-induced hyperglycemic rats [PMID:16688478].

Preuve DHepatocellular Carcinoma

Juice concentrations above 0.1% induced apoptosis and DNA damage in HepG2 cell lines [PMID:26320494].

Sécurité et effets indésirables

A 14-day subacute oral toxicity study in rats using ethanol leaf extracts (up to 600 mg/kg) did not cause significant changes in body weight, food consumption, or liver and kidney function parameters [PMID:23593574].

Interactions médicamenteuses

The bioactive subfraction F3 exhibited relatively weak inhibition of CYP2B6, CYP2C19, CYP2D6, and CYP3A4 enzymes [PMID:35146636].

Synthèse des preuves

The current evidence is primarily based on in vitro cell lines and in vivo animal models (predominantly rats and mice), indicating promising anticancer, antihyperglycemic, and antioxidant properties; however, there are no human clinical trials provided.

Sources PubMed

1.PMID: 36046107 (2022) — The complete chloroplast genome of Strobilanthes crispus (Acanthaceae). · Mitochondrial DNA. Part B, Resources
2.PMID: 30594607 (2019) — Strobilanthes crispus inhibits migration, invasion and metastasis in breast cancer. · Journal of ethnopharmacology
3.PMID: 33127562 (2021) — Strobilanthes crispus bioactive subfraction inhibits tumor progression and improves hematological and morphological parameters in mouse mammary carcinoma model. · Journal of ethnopharmacology
4.PMID: 35972917 (2022) — Strobilanthes crispus elicits anti-tumor immunogenicity in in vitro and in vivo metastatic breast carcinoma. · PloS one
5.PMID: 42005722 (2026)

Strobilanthes Crispus

Sources et citations